Research targets treatments for Marfan syndrome, aortic dissections

A blood test that identifies enlarged aortas before they rupture shows promise for patients with Marfan syndrome and others with risk factors for the deadly condition, according to a study led by Dr. Hal Dietz of Johns Hopkins University, who has been studying Marfan for decades. Dietz and his team also discovered that a blood pressure medication, losartan, blocks the protein involved in Marfan and seems to reverse some of its effects and stem abnormal growth of the aorta.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC